期刊文献+

A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B 被引量:48

A randomized controlled clinical trial on the treatment of Thymosin-a1 versus interferon-α in patients with hepatitis B
在线阅读 下载PDF
导出
摘要 INTRODUCTIONChronic hepatitis B virus (HBV) infection is a serious problem because of its world wide distribution and possible adverse sequelae ,such as cirrhosis and hepatocellular carcinoma .The World Health Organization estimates that HBV has infected mord than 350 million people worldwide ,and up to 20% of them will become chromic carricrs and will be at significant risk for cirrhosis and HCC .The ultimate goal of the therapy for chronic hepatitis B is to prevent progression to cirrhosis and to prevent development of HCC.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第3期411-414,共4页 世界胃肠病学杂志(英文版)
关键词 HEPATITIS B/therapy THYMOSIN INTERFERON-ALPHA HEPATITIS B virus randomized controlled trials hepatitis B/therapy Thymosin interferon-alpha hepatitis B virus randomized controlled trials
  • 相关文献

参考文献5

共引文献25

同被引文献366

引证文献48

二级引证文献419

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部